12.950
+1,17%
2026-10-19
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -60.8% | +125.6% | 2 / 3 | +2.9% | +4.44 pp | -4.89 pp | +1.2% | 1.89 | 74.95 | 752 | +2,9% | 55,3 | −38,2% | 74.95 | 22.93 | +226,9% |
| Pts | 0 | 12 | 8 | 0 | 12 | 0 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 12.950 (close price on 2026-10-19)EPS (TTM): 172,8
Financial charts
1.Revenue & growth
VND bn751Q2/26
1.Revenue & growth
VND bn751Q2/26
2.Profit & growth
VND bn11,7Q2/26
3.Profit mix (Penman)
VND bn359Q2/26
4.Margins & cost structure
%55.5%Q2/26
5.Returns & cash cycle
% · days3.1%Q2/26
6.Earnings quality & cash
VND bn-1.408Q2/26
7.Asset structure
VND bn43.467Q2/26
8.Funding & debt health
VND bn · times43.467Q2/26
9.Revenue backlog
VND bn130Q2/26
10.Valuation
times · %79,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %17Q2/26
Adjusted EPS growth, latest quarter
-62.2%
Average adjusted EPS growth, 3 quarters
-27.1%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
7.5%
Source: vnstockData through Q2/26